TY - JOUR AU - Gómez-Outes, A. AU - Terleira-Fernández, A. I. AU - Calvo-Roja, G. AU - Suárez-Gea, M. L. AU - Vargas-Castrillón, E. PY - 2013 DA - 2013// TI - Dabigatran, rivaroxaban, or apixaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-­-analysis of subgroups JO - Thrombosis VL - 2013 UR - https://doi.org/10.1155/2013/640723 DO - 10.1155/2013/640723 ID - Gómez-Outes2013 ER - TY - JOUR AU - Rahman, F. PY - 2014 DA - 2014// TI - Global epidemiology of atrial fibrillation JO - Nat Rev Cardiol VL - 11 UR - https://doi.org/10.1038/nrcardio.2014.118 DO - 10.1038/nrcardio.2014.118 ID - Rahman2014 ER - TY - BOOK PY - 2014 DA - 2014// TI - Atrial fibrillation: management clinical guideline CG180 ID - ref3 ER - TY - JOUR AU - Burn, J. AU - Pirmohamed, M. PY - 2018 DA - 2018// TI - Direct oral anticoagulants versus warfain: is new always better than the old? JO - Open Heart VL - 5 UR - https://doi.org/10.1136/openhrt-2017-000712 DO - 10.1136/openhrt-2017-000712 ID - Burn2018 ER - TY - JOUR AU - Klein, T. E. AU - Altman, R. B. AU - Eriksson, N. PY - 2009 DA - 2009// TI - Estimation of the warfarin dose with clinical and pharmacogenetic data JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0809329 DO - 10.1056/NEJMoa0809329 ID - Klein2009 ER - TY - JOUR AU - D’Andrea, G. AU - D’Ambrosio AU - Perna, R. D. PY - 2005 DA - 2005// TI - A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin JO - Blood VL - 2005 UR - https://doi.org/10.1182/blood-2004-06-2111 DO - 10.1182/blood-2004-06-2111 ID - D’Andrea2005 ER - TY - JOUR AU - Aithal, G. AU - Day, C. AU - Kesteven, P. AU - Daly, A. PY - 1999 DA - 1999// TI - Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications JO - Lancet VL - 353 UR - https://doi.org/10.1016/S0140-6736(98)04474-2 DO - 10.1016/S0140-6736(98)04474-2 ID - Aithal1999 ER - TY - JOUR AU - Pirmohamed, M. AU - Burnside, G. AU - Eriksson, N. PY - 2013 DA - 2013// TI - A randomized trial of genotype-­-guided dosing of warfarin JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1311386 DO - 10.1056/NEJMoa1311386 ID - Pirmohamed2013 ER - TY - BOOK PY - 2014 DA - 2014// TI - Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor) diagnostics guidance ID - ref9 ER - TY - JOUR AU - Sharma, P. AU - Scotland, G. AU - Cruickshank, M. AU - Tassie, E. AU - Fraser, C. AU - Burton, C. PY - 2015 DA - 2015// TI - The clinical effectiveness and cost-­-effectiveness of point-­-of-­-care tests (CoaguChek system, INRatio2 PT/INR monitor and ProTime microcoagulation system) for the self-­-monitoring of the coagulation status of people receiving long-­-term vitamin K antagonist therapy, compared with standard UK practice: systematic review and economic evaluation JO - Health Technol Assess VL - 19 UR - https://doi.org/10.3310/hta19480 DO - 10.3310/hta19480 ID - Sharma2015 ER - TY - JOUR AU - Matchar, D. B. AU - Jacobson, A. AU - Dolor, R. AU - Edson, R. AU - Uyeda, L. AU - Phibbs, C. S. AU - Vertrees, J. E. AU - Shih, M. C. AU - Holodniy, M. AU - Lavori, P. PY - 2010 DA - 2010// TI - Effect of home testing of international normalized ratio on clinical events JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1002617 DO - 10.1056/NEJMoa1002617 ID - Matchar2010 ER - TY - STD TI - Health call INR monitoring project by County Durham and Darlington Foundation Trust, Roche and Inhealthcare. http://connect.qualityincare.org/anticoagulation/pharmacy/case_studies/health_call_inr_monitoring_project_by_county_durham_and_darlington_foundation_trust_roche_and_inheAlthcare. UR - http://connect.qualityincare.org/anticoagulation/pharmacy/case_studies/health_call_inr_monitoring_project_by_county_durham_and_darlington_foundation_trust_roche_and_inheAlthcare ID - ref12 ER - TY - STD TI - ONS Annual Survey of hours and earnings 2018 – provisional results Median (Minimum) UK Wage 2018. ID - ref13 ER - TY - STD TI - Department of Transport TAG Unit 1.3.1 user and provider impacts May 2018 market price values. ID - ref14 ER - TY - JOUR AU - Sawicki, P. T. PY - 1999 DA - 1999// TI - A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation JO - JAMA VL - 281 UR - https://doi.org/10.1001/jama.281.2.145 DO - 10.1001/jama.281.2.145 ID - Sawicki1999 ER - TY - JOUR AU - Gadisseur, A. P. A. AU - Kaptein, A. A. AU - Breuking-Engbers, W. G. M. PY - 2004 DA - 2004// TI - Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life JO - J Thromb Haemost VL - 24 UR - https://doi.org/10.1111/j.1538-7836.2004.00659.x DO - 10.1111/j.1538-7836.2004.00659.x ID - Gadisseur2004 ER - TY - STD TI - Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. ID - ref17 ER - TY - BOOK PY - 2018 DA - 2018// TI - R1.0 PB - TreeAge Software CY - Williamstown ID - ref18 ER - TY - JOUR AU - Janzic, A. AU - Jos, M. PY - 2015 DA - 2015// TI - Cost-effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control JO - PharmacoEconomics VL - 33 UR - https://doi.org/10.1007/s40273-014-0246-7 DO - 10.1007/s40273-014-0246-7 ID - Janzic2015 ER - TY - STD TI - Excellence NIfHaC. Guide to the methods of technology appraisal 2013 [cited 12]. Available from: https://www.nice.org.uk/process/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781. UR - https://www.nice.org.uk/process/pmg9/resources/guide-to-the-methods-of-technology-appraisal-2013-pdf-2007975843781 ID - ref20 ER -